Articles by ‘Bharti Moore’

UK Finance has just published its 2020 Half Year Fraud report, which revealed that in the first half of the year, a total of £207.8 million was lost to authorised push payment (APP) fraud.

The UK BioIndustry Association, BIA, has just released its investment report for the period 1 June to 31 August 2020.

With the end of the Brexit transition period fast approaching it is becoming more and more urgent for businesses in the medical sector to prepare for the transition period coming to an end. It is a sector, where many of the rules stem from EU regulation, which makes it even more important for businesses to prepare.

Since its launch in May 2020, the Future Fund has proven to be extremely popular, with applications in excess of the initially funding commitment of £250million.

In the wake of the controversy surrounding the allegations of modern slavery of a Leicester factory supplying online fashion brand Boohoo, now is not the time for Boards to take their eyes off the ball.

As the social, economic, and health impacts of COVID continue to ripple around the globe, it would seem that the UK Biotech sector is weathering the storm. But despite its robust response, there are warming signs that should not be ignored.

Despite the ongoing challenges faced by UK businesses, as lockdown measures ease and businesses start to re-open and adjust to a new way of working, directors across all sectors will be looking ahead and need to maintain a ‘hands on’ approach to considering, implementing and communicating key decisions.

On 20 April 2020, the Chancellor of the Exchequer, Rishi Sunak announced a scheme aimed at providing support to start-up businesses not eligible for existing coronavirus rescue measures, in the form of the Future Fund.

There has been much publicity about the various support measures and schemes put in place to support businesses affected by COVID-19 such as the Coronavirus Business Interruption Loan Scheme (CBILS) and the Job Retention Scheme. One of the less publicised measures is specific support for UK businesses trading abroad.

During the coronavirus pandemic, the Chancellor of the Exchequer, Rishi Sunak announced financial support available to small to medium business, later expanding the relief package to larger business. Amidst the chaos, the entrepreneur and start-up community have fallen through the cracks.

Over the last few months, the world has changed dramatically. The International Monetary Fund, published its World Economic Outlook on 14 April 2020, which projects global growth in 2020 to fall to -3% as a result of Covid-19.

In light of the Coronavirus outbreak the Medicines and Healthcare products Regulatory Authority (MHRA), which is the authority which supervises the Medical Device and Pharmaceutical sector, has recently released a series of guidance notes about how the MHRA will deal with certain aspects of the Life Sciences sector during the COVID-19 outbreak.